Related Experiment Video
Updated: Feb 7, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
Synthesis and Evaluation of Fuligocandin B Derivatives with Activity for Overcoming TRAIL Resistance
Midori A Arai1, Ayaka Masuda1, Akiko Suganami2
1Graduate School of Pharmaceutical Sciences, Chiba University.
Abstract:
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling pathway induces apoptosis in cancer cells but not in normal cells. Therefore, this pathway has attracted attention regarding possible clinical treatment of cancer. However, many cancer cells demonstrate TRAIL resistance. To overcome this problem, small molecules that sensitize cancer cells to TRAIL are desired. Heterocyclic derivatives of the natural product, fuligocandin B (2), with activity for overcoming TRAIL resistance were synthesized, and their activity was evaluated. Of the synthetic molecules, the quinoline derivative (10g) showed potent activity against TRAIL-resistant gastric adenocarcinoma cells. After a docking study of the target protein valosin-containing protein, 7'-amino fuligocandin B (10m) was designed and synthesized. Compound 10m also showed good activity for overcoming TRAIL resistance. 10m produced a 49.7% difference in viability with TRAIL at 30 µM compared to without TRAIL. This activity was better than that of fuligocandin B (2).
Insights
Researchers synthesized novel compounds to overcome cancer cell resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) therapy. A quinoline derivative and a modified fuligocandin B derivative showed significant potential in sensitizing resistant cancer cells to TRAIL-induced apoptosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway triggers apoptosis in cancer cells, offering therapeutic potential.
- TRAIL resistance in cancer cells is a significant clinical challenge, necessitating strategies to enhance TRAIL sensitivity.
- Small molecules that can overcome TRAIL resistance are crucial for developing effective cancer treatments.
Purpose of the Study:
- To synthesize and evaluate novel heterocyclic derivatives of fuligocandin B for their ability to overcome TRAIL resistance in cancer cells.
- To identify potent compounds that can sensitize TRAIL-resistant cancer cells to apoptosis induction.
- To explore structure-activity relationships and design improved TRAIL sensitizers.
Main Methods:
- Synthesis of heterocyclic derivatives based on the natural product fuligocandin B.
- Evaluation of synthesized compounds for their activity in sensitizing TRAIL-resistant cancer cells.
- In silico molecular docking studies to identify potential target proteins, such as valosin-containing protein.
- Design and synthesis of new derivatives based on docking study insights.
Main Results:
- Several synthesized heterocyclic derivatives demonstrated activity in overcoming TRAIL resistance.
- A specific quinoline derivative (10g) exhibited potent activity against TRAIL-resistant gastric adenocarcinoma cells.
- Compound 10m (7'-amino fuligocandin B), designed after docking studies, showed significant TRAIL-sensitizing activity.
- Compound 10m demonstrated superior efficacy compared to the parent compound fuligocandin B in sensitizing cells to TRAIL.
Conclusions:
- Novel fuligocandin B derivatives, particularly quinoline and 7'-amino derivatives, are effective in overcoming TRAIL resistance in cancer cells.
- These compounds hold promise as potential therapeutic agents to enhance the efficacy of TRAIL-based cancer treatments.
- Further investigation into the mechanism of action and in vivo efficacy of these compounds is warranted.
More Related Videos
08:38Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Published on: April 9, 2012
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
Related Concept Videos
Dehydration Synthesis
Dehydration synthesis (also called a condensation reaction) is the chemical process in which two molecules covalently link together to form a new molecule, along with the release of a water molecule. Many physiologically important compounds form by dehydration synthesis reactions, such as complex carbohydrates, proteins, DNA, and RNA.
Synthesis of carbohydrates
Sugar molecules are covalently linked together by dehydration synthesis. During the reaction, the hydroxyl (-OH) group from...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance
Synthesis and Decomposition Reactions
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...